Drugs / 99mTc-HYNIC-Annexin A5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00319059 | Mar → Apr 2006 | adenosine monophosphate deaminase deficiency, ischemic disease | Radboud University Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-HYNIC-Annexin A5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00319059 ↗ |
| Modality | Diagnostic / imaging agent | “99mTc-Annexin A5 scintigraphy” NCT00319059 ↗ |
| Route | Intravenous | “administered intravenously” NCT00319059 ↗ |